Nasus Pharma Ltd.

NSRX | AMEX

Price Alert Chart Builder DCF Calculator

$3.16

-$0.15 (-4.53%)

At close: Oct 30, 2026, 3:59 PM ET

$3.16

$0.00 (0.00%)

After-hours: Oct 30, 2026, 3:59 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025
Cash & Equivalents	1.24M
Short-Term Investments	3.05M
Long-Term Investments	n/a
Other Long-Term Assets	n/a
Receivables	n/a
Inventory	n/a
Other Current Assets	240K
Total Current Assets	4.86M
Property-Plant & Equipment	149K
Goodwill & Intangibles	n/a
Total Long-Term Assets	149K
Total Assets	5M
Account Payables	829K
Deferred Revenue	n/a
Short-Term Debt	n/a
Other Current Liabilities	736K
Total Current Liabilities	2.16M
Long-Term Debt	n/a
Other Long-Term Liabilities	n/a
Total Long-Term Liabilities	73K
Total Liabilities	2.24M
Total Debt	118K
Book Value	2.77M
Book Value Per Share	0.35
Common Stock	n/a
Retained Earnings	-18.52M
Comprehensive Income	n/a
Shareholders Equity	2.77M
Total Investments	3.05M